The control of ccn2*(ctgf) gene expression in normal and scleroderma fibroblasts

被引:108
作者
Leask, A
Sa, S
Holmes, A
Shiwen, X
Black, CM
Abraham, DJ
机构
[1] Fibrogen Inc, San Francisco, CA 94080 USA
[2] UCL Royal Free & Univ Coll, Sch Med, Ctr Rheumatol, London NW3 2PF, England
来源
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY | 2001年 / 54卷 / 03期
关键词
connective tissue growth factor; scleroderma; transforming growth factor beta;
D O I
10.1136/mp.54.3.180
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Although the role of transforming growth factor beta (TGF beta) in initiating fibrosis is well established, the role that TGF beta plays in maintaining fibrosis is unclear. The gene encoding connective tissue growth factor (ccn2; ctgf), which promotes fibrosis, is not normally expressed in dermal fibroblasts unless TGF beta is present. However, in dermal fibroblasts cultured from lesional areas of scleroderma, ccn2 (ctgf) is expressed constitutively. The contribution of several elements in the ccn2 (ctgf) promoter to basal and TGF beta induced ccn2 (ctgf) expression in normal and scleroderma fibroblasts has been investigated. A functional SMAD binding site in the ccn2 (ctgf) promoter that is necessary for the TGF beta mediated induction of this gene has been identified. The previously termed TGF beta responsive enhancer (TGF beta RE) in the ccn2 (ctgf) promoter has been found to be necessary for basal promoter activity in normal fibroblasts. The SMAD element is not necessary for the high ccn2 (ctgf) promoter activity seen in scleroderma fibroblasts. However, mutation of the previously termed TGF beta RE reduces ccn2 (ctgf) promoter activity in scleroderma fibroblasts to that seen in normal fibroblasts. Thus, the maintenance of the scleroderma phenotype, as assessed by a high degree of ccn2 (ctgf) promoter activity, appears to be relatively independent of SMAD action and seems to reflect increased basal promoter activity.
引用
收藏
页码:180 / 183
页数:4
相关论文
共 41 条
[31]   Transcriptional regulation of connective tissue growth factor by cortisol in osteoblasts [J].
Pereira, RC ;
Durant, D ;
Canalis, E .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2000, 279 (03) :E570-E576
[32]   Expression of TGF-β1, -β2 and -β3 in localized and systemic scleroderma [J].
Querfeld, C ;
Eckes, B ;
Huerkamp, C ;
Krieg, T ;
Sollberg, S .
JOURNAL OF DERMATOLOGICAL SCIENCE, 1999, 21 (01) :13-22
[33]   Regulation of connective tissue growth factor expression by prostaglandin E2 [J].
Ricupero, DA ;
Rishikof, DC ;
Kuang, PP ;
Poliks, CF ;
Goldstein, RH .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1999, 277 (06) :L1165-L1171
[34]  
Sato S, 2000, J RHEUMATOL, V27, P149
[35]   TGF-β-induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CREB-binding protein [J].
Shen, X ;
Hu, PP ;
Liberati, NT ;
Datto, MB ;
Frederick, JP ;
Wang, XF .
MOLECULAR BIOLOGY OF THE CELL, 1998, 9 (12) :3309-3319
[36]   Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis [J].
Shi-Wen, X ;
Pennington, D ;
Holmes, A ;
Leask, A ;
Bradham, D ;
Beauchamp, JR ;
Fonseca, C ;
du Bois, RM ;
Martin, GR ;
Black, CM ;
Abraham, DJ .
EXPERIMENTAL CELL RESEARCH, 2000, 259 (01) :213-224
[37]   Inhibition of endogenous expression of connective tissue growth factor by its antisense oligonucleotide and antisense RNA suppresses proliferation and migration of vascular endothelial cells [J].
Shimo, T ;
Nakanishi, T ;
Kimura, Y ;
Nishida, T ;
Ishizeki, K ;
Matsumura, T ;
Takigawa, M .
JOURNAL OF BIOCHEMISTRY, 1998, 124 (01) :130-140
[38]   A POSSIBLE ROLE FOR TRANSFORMING GROWTH-FACTOR-BETA IN SYSTEMIC-SCLEROSIS [J].
SMITH, EA ;
LEROY, EC .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1990, 95 (06) :S125-S127
[39]   Identification of connective tissue growth factor as a target of WT1 transcriptional regulation [J].
Stanhope-Baker, P ;
Williams, BRG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (49) :38139-38150
[40]   Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-Akt-dependent pathways in retinal vascular cells [J].
Suzuma, K ;
Naruse, K ;
Suzuma, I ;
Takahara, N ;
Ueki, K ;
Aiello, LP ;
King, GL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (52) :40725-40731